VANCOUVER, BRITISH COLUMBIA and BURLINGAME, CALIFORNIA--(MARKET WIRE)--Jun 26, 2006 -- Inflazyme Pharmaceuticals Ltd. (TSX:IZP.TO - News) and BioSeek, Inc. announced today that they have entered into a research collaboration agreement. Under the collaboration, BioSeek, a leader in applying integrated human biology systems for developing new therapeutics, will apply its proprietary BioMAP® Systems in an effort to characterize the mechanisms of action of the LSAIDs(TM), Inflazyme’s Leukocyte Selective Anti-inflammatory Drugs, which make up Inflazyme’s respiratory program. Inflazyme Pharmaceuticals is a biopharmaceutical company focused on respiratory and inflammatory diseases. Financial terms of the agreement were not disclosed.
